Bénédicte Menn

Privat kapitalinvesterare på

Oxford University Innovation Ltd.

Consumer Services

Finance

Health Technology

Profil

Bénédicte Menn founded Neurokin SA in 2003, where she worked as Project Leader from 2009 to 2014.
Dr. Menn also currently works at Oxford University Innovation Ltd., as Senior Investment Manager.
Dr. Menn received her undergraduate degree in 1990 from Ecole Nationale d'Administration.

Aktiva positioner av Bénédicte Menn

Företag	Position	Start
Oxford University Innovation Ltd. Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements.	Privat kapitalinvesterare	2017-01-01

Alla aktiva positioner av Bénédicte Menn

Tidigare kända positioner av Bénédicte Menn

Företag	Position	Slut
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Grundare	2014-03-11

Se detaljerna i Bénédicte Menns erfarenhet

Bénédicte Menns utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Bénédicte Menns erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	3
Ecole Nationale d'Administration Ecole Nationale d'Administration Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oxford University Innovation Ltd. Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements.	Finance
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Health Technology